The Birgi Mefar Group is a leading Turkish pharmaceuticals contract manufacturing and services group, servicing many of the world’s leading pharmaceutical companies through a fully integrated business model.

The Group is primarily focused on pharmaceutical formulations in injectable form. The Group also provides value added ancillary services and logistics to its clients.

Stage Capital backed the leveraged buy out of Birgi Mefar in June 2011.

HEADQUARTERS
Istanbul, Turkey

INVESTMENT DATE
June 2011

INVESTMENT THESIS
LBO

STATUS
Current

INDUSTRY
Pharmaceuticals

STAGE CAPITAL TEAM
Mete Ikiz